Boston Scientific Statistics
Total Valuation
BSX has a market cap or net worth of $101.41 billion. The enterprise value is $109.65 billion.
| Market Cap | 101.41B |
| Enterprise Value | 109.65B |
Important Dates
The next confirmed earnings date is Wednesday, April 24, 2024, before market open.
| Earnings Date | Apr 24, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
BSX has 1.47 billion shares outstanding. The number of shares has increased by 1.65% in one year.
| Shares Outstanding | 1.47B |
| Shares Change (YoY) | +1.65% |
| Shares Change (QoQ) | +0.12% |
| Owned by Insiders (%) | 0.19% |
| Owned by Institutions (%) | 94.47% |
| Float | 1.46B |
Valuation Ratios
The trailing PE ratio is 64.48 and the forward PE ratio is 30.31. BSX's PEG ratio is 1.80.
| PE Ratio | 64.48 |
| Forward PE | 30.31 |
| PS Ratio | 7.12 |
| Forward PS | 6.44 |
| PB Ratio | 5.26 |
| P/FCF Ratio | 55.54 |
| PEG Ratio | 1.80 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 31.81, with an EV/FCF ratio of 60.05.
| EV / Earnings | 69.84 |
| EV / Sales | 7.70 |
| EV / EBITDA | 31.81 |
| EV / EBIT | 48.71 |
| EV / FCF | 60.05 |
Financial Position
The company has a current ratio of 1.32, with a Debt / Equity ratio of 0.47.
| Current Ratio | 1.32 |
| Quick Ratio | 0.63 |
| Debt / Equity | 0.47 |
| Debt / EBITDA | 2.64 |
| Debt / FCF | 4.98 |
| Interest Coverage | 8.49 |
Financial Efficiency
Return on equity (ROE) is 8.50% and return on invested capital (ROIC) is 6.62%.
| Return on Equity (ROE) | 8.50% |
| Return on Assets (ROA) | 4.60% |
| Return on Capital (ROIC) | 6.62% |
| Revenue Per Employee | $296,667 |
| Profits Per Employee | $32,708 |
| Employee Count | 48,000 |
| Asset Turnover | 0.42 |
| Inventory Turnover | 2.00 |
Taxes
In the past 12 months, BSX has paid $393.00 million in taxes.
| Income Tax | 393.00M |
| Effective Tax Rate | 20.02% |
Stock Price Statistics
The stock price has increased by +34.38% in the last 52 weeks. The beta is 0.79, so BSX's price volatility has been lower than the market average.
| Beta (1Y) | 0.79 |
| 52-Week Price Change | +34.38% |
| 50-Day Moving Average | 67.30 |
| 200-Day Moving Average | 57.68 |
| Relative Strength Index (RSI) | 59.60 |
| Average Volume (30 Days) | 6,381,241 |
Short Selling Information
The latest short interest is 12.43 million, so 0.85% of the outstanding shares have been sold short.
| Short Interest | 12.43M |
| Short Previous Month | 9.44M |
| Short % of Shares Out | 0.85% |
| Short % of Float | 0.85% |
| Short Ratio (days to cover) | 2.01 |
Income Statement
In the last 12 months, BSX had revenue of $14.24 billion and earned $1.57 billion in profits. Earnings per share was $1.07.
| Revenue | 14.24B |
| Gross Profit | 9.90B |
| Operating Income | 2.34B |
| Pretax Income | 1.99B |
| Net Income | 1.57B |
| EBITDA | 3.45B |
| EBIT | 2.25B |
| Earnings Per Share (EPS) | $1.07 |
Balance Sheet
The company has $865.00 million in cash and $9.10 billion in debt, giving a net cash position of -$8.24 billion or -$5.60 per share.
| Cash & Cash Equivalents | 865.00M |
| Total Debt | 9.10B |
| Net Cash | -8.24B |
| Net Cash Per Share | -$5.60 |
| Equity / Book Value | 19.28B |
| Book Value Per Share | 13.12 |
| Working Capital | 1.58B |
Cash Flow
In the last 12 months, operating cash flow was $2.50 billion and capital expenditures -$677.00 million, giving a free cash flow of $1.83 billion.
| Operating Cash Flow | 2.50B |
| Capital Expenditures | -677.00M |
| Free Cash Flow | 1.83B |
| FCF Per Share | $1.26 |
Margins
Gross margin is 69.49%, with operating and profit margins of 16.45% and 11.03%.
| Gross Margin | 69.49% |
| Operating Margin | 16.45% |
| Pretax Margin | 13.95% |
| Profit Margin | 11.03% |
| EBITDA Margin | 24.21% |
| EBIT Margin | 15.81% |
| FCF Margin | 12.82% |
Dividends & Yields
BSX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.65% |
| Shareholder Yield | -1.65% |
| Earnings Yield | 1.55% |
| FCF Yield | 1.80% |
Analyst Forecast
The average price target for BSX is $68.04, which is -1.38% lower than the current price. The consensus rating is "Strong Buy".
| Price Target | $68.04 |
| Price Target Difference | -1.38% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 23 |
| Revenue Growth Forecast (5Y) | 8.78% |
| EPS Growth Forecast (5Y) | 27.00% |
Stock Splits
The last stock split was on November 6, 2003. It was a forward split with a ratio of 2:1.
| Last Split Date | Nov 6, 2003 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
BSX has an Altman Z-Score of 4.6 and a Piotroski F-Score of 7.
| Altman Z-Score | 4.6 |
| Piotroski F-Score | 7 |